Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Long-Lasting AML-Specific Antibody Responses after Allogeneic Hematopoietic Progenitor Cell Transplantation

Rogers Nahui Palomino, Etsuko Yasuda, Nienke Haverkate, Hergen Spits, Tim Beaumont, Bianca Blom, Mette D. Hazenberg

Blood (2024) 144 (Supplement 1): 2011.

https://doi.org/10.1182/blood-2024-207046

Published: 2024

Journal Articles

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-134088

Published: 2020

Journal Articles

AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia

Greta De Jong, Sophie E Levie, Remko Schotte, PhD, Wouter Pos, PhD, Daniel Go, Etsuko Yasuda, Madalina Cercel, Susan E van Hal-van Veen, Esmay Frankin, Anikó Szabó, MD, Julien Villaudy, PhD, Pauline M van Helden, PhD, Hans van Eenennaam, PhD, Hergen Spits, PhD, Anita W Rijneveld, MD PhD, Mette D Hazenberg, MD PhD

Blood (2019) 134 (Supplement_1): 4461.

https://doi.org/10.1182/blood-2019-127894

Published: 2019

Journal Articles

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

Marijn A. Gillissen, Martijn Kedde, Greta de Jong, Gemma Moiset, Etsuko Yasuda, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Koen Wagner, Martino Böhne, Paul J. Hensbergen, Dave Speijer, Pauline M. van Helden, Tim Beaumont, Hergen Spits, Mette D. Hazenberg

Blood (2018) 131 (1): 131–143.

https://doi.org/10.1182/blood-2017-02-768762

Published: 2018

Includes: Supplemental data

Journal Articles

Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Marijn A. Gillissen, MD, Martijn Kedde, PhD, Greta de Jong, MD, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Marie Jose Kersten, MD PhD, Paul Hensbergen, PhD, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD

Blood (2016) 128 (22): 1646.

https://doi.org/10.1182/blood.V128.22.1646.1646

Published: 2016

Journal Articles

AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia

Marijn Aletta Gillissen, MD, Sophie E. Levie, Greta de Jong, MD, Etsuko Yasuda, PhD, Arjen Q. Bakker, Pauline M. van Helden, PhD, Douglas M. Jefferson, PhD, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD

Blood (2015) 126 (23): 5473.

https://doi.org/10.1182/blood.V126.23.5473.5473

Published: 2015

Journal Articles

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Marijn Aletta Gillissen, MD, Martijn Kedde, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Martino Bohne, Dave Speijer, PhD, Daisy I. Picavet, Jan Stap, Marinus H. J. van Oers, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD

Blood (2015) 126 (23): 3146.

https://doi.org/10.1182/blood.V126.23.3146.3146

Published: 2015

Journal Articles

Unique and Potent Tumor Specific Antibodies in Graft Versus Leukemia Responses

Marijn A. Gillissen, MD, Etsuko Yasuda, PhD, Sophie Levie, Arjen Q Bakker, Martijn Kedde, Yvonne B Claassen, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Tim Beaumont, PhD, Mette D. Hazenberg, MD PhD

Blood (2014) 124 (21): 3826.

https://doi.org/10.1182/blood.V124.21.3826.3826

Published: 2014

Journal Articles

Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease

J. Marius Munneke, Andreas T. Björklund, Jenny M. Mjösberg, Karin Garming-Legert, Jochem H. Bernink, Bianca Blom, Cynthia Huisman, Marinus H. J. van Oers, Hergen Spits, Karl-Johan Malmberg, Mette D. Hazenberg

Blood (2014) 124 (5): 812–821.

https://doi.org/10.1182/blood-2013-11-536888

Published: 2014

Includes: Supplemental data

Journal Articles

Human innate lymphoid cells

Mette D. Hazenberg, Hergen Spits

Blood (2014) 124 (5): 700–709.

https://doi.org/10.1182/blood-2013-11-427781

Published: 2014

Journal Articles

New Insights in Development and Function of Human Innate Lymphoid Cells

Hergen Spits, PhD, Jochem Bernink, Charlotte Peters, Jenny Mjosberg

Blood (2012) 120 (21): SCI-19.

https://doi.org/10.1182/blood.V120.21.SCI-19.SCI-19

Published: 2012

Journal Articles

Reconstitution of Innate Lymphoid Cells After Hematopoietic Stem Cell Transplantation

J. Marius Munneke, MD, Jenny M. Mjösberg, PhD, Jochem H.J. Bernink, Cynthia Huisman, MD, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD, PhD

Blood (2012) 120 (21): 4104.

https://doi.org/10.1182/blood.V120.21.4104.4104

Published: 2012

Journal Articles

Stem Cell Factor (SCF) Improves Thymopoiesis After Experimental Hematopoietic Stem Cell Transplantation In Both a Murine BMT Model and In “human Immune system” (HIS) Mice, Receiving a Human Stem Cell Graft.

Elwin J Rombouts, PhD, Evert-Jan Wils, Irene Van Mourik, Nicolas Legrand, PhD, Hergen Spits, Prof., Dr., Jan J. Cornelissen, MD, PhD

Blood (2010) 116 (21): 3725.

https://doi.org/10.1182/blood.V116.21.3725.3725

Published: 2010

Journal Articles

Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression

Heike Schmidlin, Sean A. Diehl, Maho Nagasawa, Ferenc A. Scheeren, Remko Schotte, Christel H. Uittenbogaart, Hergen Spits, Bianca Blom

Blood (2008) 112 (5): 1804–1812.

https://doi.org/10.1182/blood-2008-01-136440

Published: 2008

Includes: Supplemental data

Journal Articles

IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis

Ferenc A. Scheeren, Sean A. Diehl, Laura A. Smit, Tim Beaumont, Marianne Naspetti, Richard J. Bende, Bianca Blom, Kennosuke Karube, Koichi Ohshima, Carel J. M. van Noesel, Hergen Spits

Blood (2008) 111 (9): 4706–4715.

https://doi.org/10.1182/blood-2007-08-105643

Published: 2008

Includes: Supplemental data

Journal Articles

Stimulated plasmacytoid dendritic cells impair human T-cell development

Heike Schmidlin, Wendy Dontje, Fedde Groot, Suzanne J. Ligthart, Arnaud D. Colantonio, Monique E. Oud, Esther J. Schilder-Tol, Marcel Spaargaren, Hergen Spits, Christel H. Uittenbogaart, Bianca Blom

Blood (2006) 108 (12): 3792–3800.

https://doi.org/10.1182/blood-2006-02-004978

Published: 2006

Includes: Supplemental data

Journal Articles

Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in “human immune system” Rag2 -/- γ c -/- mice

Nicolas Legrand, Tom Cupedo, Anja U. van Lent, Menno J. Ebeli, Kees Weijer, Thomas Hanke, Hergen Spits

Blood (2006) 108 (1): 238–245.

https://doi.org/10.1182/blood-2006-01-0190

Published: 2006

Includes: Supplemental data

Journal Articles

Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B

Wendy Dontje, Remko Schotte, Tom Cupedo, Maho Nagasawa, Ferenc Scheeren, Ramon Gimeno, Hergen Spits, Bianca Blom

Blood (2006) 107 (6): 2446–2452.

https://doi.org/10.1182/blood-2005-05-2090

Published: 2006

Includes: Supplemental data

Journal Articles

Monitoring the effect of gene silencing by RNA interference in human CD34 + cells injected into newborn RAG2 -/- γc -/- mice: functional inactivation of p53 in developing T cells

Ramon Gimeno, Kees Weijer, Arie Voordouw, Christel H. Uittenbogaart, Nicolas Legrand, Nuno L. Alves, Erwin Wijnands, Bianca Blom, Hergen Spits

Blood (2004) 104 (13): 3886–3893.

https://doi.org/10.1182/blood-2004-02-0656

Published: 2004

Journal Articles

Acceleration and Enhancement of T-Cell Recovery and Immune Competence by Flt3-Ligand (Flt3L) Following BMT with Low Numbers of Progenitor Cells in Immune Deficient Mice.

Evert-Jan Wils, MD, Annoek E.C. Broers, MD, Georges M.G.M. Verjans, PhD, Bert Niesters, PhD, Albert D.M.E. Osterhaus, PhD, Hergen Spits, PhD, Bob Lowenberg, MD, PhD, Gerard Wagemaker, MD, PhD, Erik Braakman, PhD, Jan J. Cornelissen, MD, PhD

Blood (2004) 104 (11): 47.

https://doi.org/10.1182/blood.V104.11.47.47

Published: 2004

NARROW

Long-Lasting AML-Specific Antibody Responses after Allogeneic Hematopoietic Progenitor Cell Transplantation

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome

AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Unique and Potent Tumor Specific Antibodies in Graft Versus Leukemia Responses

Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease

Human innate lymphoid cells

New Insights in Development and Function of Human Innate Lymphoid Cells

Reconstitution of Innate Lymphoid Cells After Hematopoietic Stem Cell Transplantation

Stem Cell Factor (SCF) Improves Thymopoiesis After Experimental Hematopoietic Stem Cell Transplantation In Both a Murine BMT Model and In “human Immune system” (HIS) Mice, Receiving a Human Stem Cell Graft.

Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression

IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis

Stimulated plasmacytoid dendritic cells impair human T-cell development

Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in “human immune system” Rag2 -/- γ c -/- mice

Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B

Monitoring the effect of gene silencing by RNA interference in human CD34 + cells injected into newborn RAG2 -/- γc -/- mice: functional inactivation of p53 in developing T cells

Acceleration and Enhancement of T-Cell Recovery and Immune Competence by Flt3-Ligand (Flt3L) Following BMT with Low Numbers of Progenitor Cells in Immune Deficient Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only